foscarnet has been researched along with guanidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dahse, H; Jahn, B; Schmidtke, M; Schnittler, U; Stelzner, A | 1 |
1 review(s) available for foscarnet and guanidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for foscarnet and guanidine
| Article | Year |
|---|---|
A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1.
Topics: Amantadine; Animals; Antiviral Agents; Cell Division; Cell Line; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Dogs; Enterovirus B, Human; Foscarnet; Guanidine; HeLa Cells; Herpesvirus 1, Human; Humans; Influenza A virus; Reproducibility of Results; Staining and Labeling; Time Factors; Viral Plaque Assay | 2001 |